Dr. Anthony J. Windebank, MD

Dr. Windebank practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Windebank's NPI, 1356321319, was assigned on January 18, 2006. Dr. Windebank graduated from Oxford University Medical School in 1975. Dr. Windebank's Minnesota license number on file is 24549.

Dr. Windebank's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Windebank's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Windebank is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Windebank to 1 more clinical lab and 1 hospice, each named with a free account. Dr. Windebank's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Windebank practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Windebank's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Windebank is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Windebank has a license on file in Minnesota.

Dmand AI lists fibromyalgia and chronic pain, hereditary polyneuropathy, neck pain and spine problems and neuropathy among the conditions Dr. Windebank treats.

CMS data shows 24 Medicare services from Dr. Windebank across 2 procedure codes in 2024, all of them office visits, for 35 Medicare patients. Medicare paid $3,914 for them. Every service was in an office.

CMS counts 35 Medicare patients who saw Dr. Windebank in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Windebank's median patient age at 60, with 48% women.

In 2024, Dr. Windebank wrote 48 Medicare Part D claims for 11 patients. 65% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $427,403 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

Dr. Windebank accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Windebank as offering telehealth.

Dmand AI links 98 papers to Dr. Windebank, published from 2005 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Spinal Cord Injuries, Rats, Sprague-Dawley and Nerve Regeneration. Dr. Windebank has published most often in Biomaterials. Dr. Windebank's most frequent co-authors are Michael J. Yaszemski, MD, Robert J. Spinner, MD and Nathan Peter Staff, MD.

Dmand AI links Dr. Windebank to 6 clinical trials, 2 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Amyotrophic Lateral Sclerosis, TDP-43 Proteinopathies and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating. Mayo Clinic sponsors the most, 4.

Dmand AI lists 1 award for Dr. Windebank, most recently America's Top Doctors in 2014.

Dr. Windebank graduated from Oxford University Medical School in 1975.

Dr. Windebank is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.